NeuRizer Ltd. (ASX:NRZ)
Australia · Delayed Price · Currency is AUD 0.0010
0.00 (0.00%)
Mar 14, 2025, 4:10 PM AEST
NeuRizer Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 0.18 | 0.57 | 1.21 | 0.44 | 22.81 |
Cash & Short-Term Investments | 0.18 | 0.57 | 1.21 | 0.44 | 22.81 |
Cash Growth | -67.70% | -53.06% | 173.36% | -98.06% | 234.77% |
Accounts Receivable | - | - | 0.02 | - | 0.26 |
Other Receivables | 0.01 | - | - | 14.65 | - |
Receivables | 0.01 | - | 0.02 | 14.65 | 0.26 |
Prepaid Expenses | 0.09 | 0 | 0.2 | 0.34 | 0.2 |
Other Current Assets | - | - | - | 0.63 | - |
Total Current Assets | 0.28 | 0.57 | 1.43 | 16.07 | 23.27 |
Property, Plant & Equipment | 129.11 | 128.13 | 126.57 | 54.22 | 31.35 |
Other Long-Term Assets | 0.61 | 0.61 | 0.66 | 21.32 | 0.57 |
Total Assets | 130 | 129.32 | 128.67 | 91.61 | 55.18 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 25.81 | 29.64 | 24.39 | 9.21 | 0.87 |
Accrued Expenses | 32.12 | 23.7 | 26.81 | 6.06 | 0.87 |
Short-Term Debt | - | - | 2.2 | 0.08 | 0.1 |
Current Portion of Long-Term Debt | 1.43 | 1 | - | - | - |
Current Portion of Leases | 0.11 | 0.1 | 0.11 | 0.05 | 0.13 |
Other Current Liabilities | 0.04 | 0.09 | 1.57 | 18.86 | 1.81 |
Total Current Liabilities | 59.52 | 54.53 | 55.07 | 34.27 | 3.77 |
Long-Term Debt | - | 0.89 | - | - | - |
Long-Term Leases | 0.03 | 0.12 | 0.14 | 0.19 | - |
Other Long-Term Liabilities | 0.6 | 0.77 | 0.71 | 0.66 | 0.11 |
Total Liabilities | 60.15 | 56.3 | 55.91 | 35.12 | 3.88 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 165.73 | 163.31 | 157.41 | 128.68 | 107.61 |
Retained Earnings | -112.78 | -106.83 | -101.23 | -84.96 | -64.57 |
Comprehensive Income & Other | 16.91 | 16.53 | 16.57 | 12.77 | 8.26 |
Shareholders' Equity | 69.85 | 73.02 | 72.75 | 56.49 | 51.3 |
Total Liabilities & Equity | 130 | 129.32 | 128.67 | 91.61 | 55.18 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 1.56 | 2.11 | 2.44 | 0.32 | 0.22 |
Net Cash (Debt) | -1.38 | -1.54 | -1.23 | 0.12 | 22.59 |
Net Cash Growth | - | - | - | -99.46% | 276.94% |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | 0.00 | 0.03 |
Filing Date Shares Outstanding | 3,403 | 2,181 | 1,269 | 1,052 | 813.48 |
Total Common Shares Outstanding | 3,358 | 1,902 | 1,246 | 954.41 | 813.48 |
Working Capital | -59.23 | -53.96 | -53.64 | -18.2 | 19.49 |
Book Value Per Share | 0.02 | 0.04 | 0.06 | 0.06 | 0.06 |
Tangible Book Value | 69.85 | 73.02 | 72.75 | 56.49 | 51.3 |
Tangible Book Value Per Share | 0.02 | 0.04 | 0.06 | 0.06 | 0.06 |
Machinery | 4.29 | 4.52 | 4.64 | 4.55 | 0.99 |